.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Xanthelasma Palpebrarum (XP) often signals underlying metabolic issues. Consequently, recent research explores Xanthelasma Palpebrarum inflammatory biomarkers to understand its pathogenesis better. Although XP is a benign periorbital lesion, it mirrors the inflammatory processes seen in atherosclerosis. Therefore, clinicians should look beyond the skin. Specifically, researchers analyzed systemic markers like the monocyte-to-HDL ratio (MHR) and the systemic immune-inflammation index (SII). In addition, they found that patients with XP exhibit significantly higher counts of neutrophils and monocytes. Moreover, the study demonstrated that a lower level of HDL cholesterol correlates with an increased risk. Furthermore, these ratios provide a clearer picture than individual lipid levels alone.
The study emphasizes that MHR, LHR, and SII serve as excellent predictive tools. For instance, the MHR showed a high sensitivity in identifying patients at risk. Because of this, these markers are valuable in clinical settings. Additionally, these findings suggest that XP is not merely a cosmetic concern. Instead, it serves as a cutaneous window into a patient's inflammatory status. In conclusion, monitoring these biomarkers provides a comprehensive view of patient health. However, further studies are needed to confirm these links. Thus, early intervention based on these signals might improve patient outcomes.
Markers like the monocyte-to-HDL ratio (MHR) and the systemic immune-inflammation index (SII) reflect systemic inflammation. In XP patients, these levels are typically elevated, suggesting that the condition is driven by an inflammatory milieu similar to early atherosclerosis.
According to recent research, MHR, LHR, and SII demonstrate high sensitivity and specificity. These composite ratios are often more effective at predicting risk than individual cell counts or standard lipid profiles.
Yes, because XP is associated with systemic inflammatory markers and dyslipidemia. Identifying these biomarkers can help clinicians assess the risk of underlying metabolic and cardiovascular diseases early.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
S\u00f6nmezo\u011flu H\u0130 et al. Investigation of systemic inflammatory biomarkers associated with high-density lipoprotein and risk analysis in Xanthelasma Palpebrarum. Cutan Ocul Toxicol. 2026 Feb 08. doi: 10.1080/15569527.2026.2626680. PMID: 41655202.
Zarei M, et al. Inflammatory Mediators in Xanthelasma Palpebrarum: Histopathologic and Immunohistochemical Study. Ophthalmic Plast Reconstr Surg. 2020;36(5):455-459.
Reddy BSN, et al. Clinical and Lipid Profile Studies in Xanthelasma Palpebrarum. Indian J Dermatol Venereol Leprol. 1983;49(3):127-131.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Study reveals that inflammatory ratios like MHR and SII, alongside low HDL levels, are significant predictors of risk in Xanthelasma Palpebrarum patients....
7 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
